Cygnet Meditech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.00 M
as on 13-12-2024
- Revenue 16.20%
(FY 2021)
- Profit 219.40%
(FY 2021)
- Ebitda 112.60%
(FY 2021)
- Net Worth 273.24%
(FY 2021)
- Total Assets 16.89%
(FY 2021)
About Cygnet Meditech
The Company is engaged in the Energy And Power Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.00 M.
Dhruvang Darji, Anjana Darji, Devang Darji, and One other member serve as directors at the Company.
- CIN/LLPIN
U33301GJ2016PTC094627
- Company No.
094627
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Dec 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cygnet Meditech Private Limited offer?
Cygnet Meditech Private Limited offers a wide range of products and services, including Scalpels, Needles & Scissors, Non Absorbable Sutures.
Who are the key members and board of directors at Cygnet Meditech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhruvang Darji  | Additional Director | 26-Jun-2023 | Current |
| Anjana Darji | Director | 07-Mar-2017 | Current |
| Devang Darji | Director | 08-Dec-2016 | Current |
| Mayankbhai Darji | Director | 08-Dec-2016 | Current |
Financial Performance of Cygnet Meditech.
Cygnet Meditech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 16.2% increase. The company also saw a substantial improvement in profitability, with a 219.4% increase in profit. The company's net worth Soared by an impressive increase of 273.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cygnet Meditech?
In 2021, Cygnet Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 26 Sep 2017 | ₹7.00 M | Open |
How Many Employees Work at Cygnet Meditech?
Unlock and access historical data on people associated with Cygnet Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cygnet Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cygnet Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
